Real-world effectiveness of ustekinumab in maintenance therapy for Crohn´s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world effectiveness of ustekinumab in maintenance therapy for Crohn´s disease

Published:2023 Issue:3 Volume:12 Page:29
ISSN:2305-2260
Container-title:Dokazatel'naya gastroenterologiya
language:en
Short-container-title:Dok. gastroenterol.

Author:

Knyazev O.V.^ORCID,Schukina O.B.^ORCID,Kagramanova A.V.^ORCID,Lishchinskaya A.A.^ORCID,Li I.A.^ORCID,Sabelnikova E.A.^ORCID,Nanaeva B.A.^ORCID,Timanovskaya M.Yu.^ORCID,Kosacheva T.A.^ORCID,Fadeeva N.A.^ORCID,Nikolskaya K.A.^ORCID,Zhulina E.Yu.,Kamzarakova N.V.^ORCID,Parfenov A.I.^ORCID

Publisher

Media Sphere Publishing Group

Subject

Gastroenterology

Reference35 articles.

1. Immunotherapy for Inflammatory Bowel Disease

2. The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?

3. Positioning Ustekinumab in Crohn’s Disease: From Clinical Evidence to Clinical Practice

4. Efficacy and safety of ustekinumab therapy in patients with Crohn’s disease. Real clinical practice

5. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3